Vorsitz: J. Dickow (Hamburg), S. Kääb (München)
(V243) | Polymorphonuclear neutrophils promote arrhythmogenesis after myocardial infarction | |
J. Grune, A. Lewis, M. Hulsmans, D. Rohde, D. Calcagno, N. Herring, K. Channon, S. Neubauer, D. Sosnovik, D. Milan, F. Swirski, K. R. King, A. D. Aguirre, P. T. Ellinor, M. Nahrendorf (Berlin, Heidelberg; 02114, La Jolla, US; Oxford, UK) | ||
Diskussion | ||
(V244) | Pharmacological screening with hiPSC-derived cardiomyocytes for mechanistic treatment of CPVT related to a novel TECRL mutation | |
F. Hohendanner, N. Göhringer, H. Stachelscheid, K. Ludwik, X. Zhou, X. Fan, I. Akin, A. S. Parwani, B. Pieske, L.-H. Boldt, I. El-Battrawy, F. R. Heinzel (Berlin, Mannheim, Bochum) | ||
Diskussion | ||
(V245) | Ventricular arrhythmias in myocarditis: Implications for clinical manifestation, diagnostics and long-term outcome | |
A.-K. Kahle, R. Güde, J. Schwarzl, P. Münkler, R. Ö. Akbulak, C. M. Jahnke, S. Bohnen, T. Würger, M. Schwarzl, F. Bönner, M. Kelm, S. Willems, U. K. Radunski, C. Meyer (Düsseldorf, Hamburg, Elmshorn) | ||
Diskussion | ||
(V246) | Substrates of ventricular arrhythmias in patients with autoimmune rheumatic diseases | |
T. Kling, M. Metani, Z. Aynur, M. Ulbrich, C. Reithmann (München) | ||
Diskussion | ||
(V247) | Serum soluble interleukin 2-receptor to monitor inflammatory activity in patients with cardiac sarcoidosis and ventricular arrhythmias | |
S. Min, M. Ulbrich, T. Kling, C. Reithmann (München) | ||
Diskussion |